---
title: "Arcutis Biotherapeutics director Christopher Peetz files initial beneficial ownership statement"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293070470.md"
description: "Arcutis Biotherapeutics director Christopher Peetz filed an initial Form 3 with the SEC, reporting indirect ownership of 187,500 common shares held through The Peetz Family Trust. This disclosure was published via EDGAR on July 17, 2026."
datetime: "2026-07-17T20:05:31.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293070470.md)
  - [en](https://longbridge.com/en/news/293070470.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293070470.md)
generator: "portal-rs"
---

# Arcutis Biotherapeutics director Christopher Peetz files initial beneficial ownership statement

-   Arcutis Biotherapeutics director Christopher Peetz filed an initial Form 3 reporting 187,500 common shares held indirectly through The Peetz Family Trust. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Arcutis Biotherapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001628280-26-048647), on July 17, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [ARQT.US](https://longbridge.com/en/quote/ARQT.US.md)

## Related News & Research

- [Arcutis Biotherapeutics director Terrie Curran disposes of 1,072 common shares worth $27,927.31](https://longbridge.com/en/news/296825308.md)
- [Arcutis director Terrie Curran disposes of common shares worth $279,129.66](https://longbridge.com/en/news/297371506.md)
- [eLong Power files Form 3 for director Kebo Qin, reports no beneficial ownership](https://longbridge.com/en/news/297217813.md)
- [Arcutis Biotherapeutics (NASDAQ:ARQT) Director Terrie Curran Sells 38,200 Shares](https://longbridge.com/en/news/297400113.md)
- [Rubrik files Form 3 as director Rakefet Russak-Aminoach reports no holdings](https://longbridge.com/en/news/297373986.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**